ROUTINE SCREENING FOR CANCER OF THE PROSTATE

被引：58

作者：

GERBER, GS ^{[1
]}

CHODAK, GW ^{[1
]}

机构：

[1] UNIV CHICAGO,PRITZKER SCH MED,DEPT SURG,BOX 403,5841 S MARYLAND AVE,CHICAGO,IL 60637

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1991年 / 83卷 / 05期

关键词：

D O I：

10.1093/jnci/83.5.329

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The value of screening for prostate cancer remains unclear. Although digital rectal examination, transrectal ultrasonography, and determination of serum prostate-specific antigen levels may lead to early detection of a malignancy, these procedures have never been shown to reduce disease-specific mortality from prostate cancer. Unfortunately, several potential errors found in uncontrolled trials may suggest benefit from screening where none exists. Only a large, randomized, controlled clinical study demonstrating decreased mortality from prostate cancer can prove that screening is beneficial. Until such a study is performed, patients should be informed of both the potential benefits and the risks of screening and treatment.

引用

页码：329 / 335

页数：7